ERβ has been shown to be expressed in the majority of invasive breast cancers including the human epithelial growth factor receptor 2 (HER2) and basal (or triple-negative) subtypes that lack ERα expression [35,36,37]. The gene discussed is ESR2; the disease is breast carcinoma.